Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (38)
Sharmila Velusamy, Syed Abuthakir Mohamed Husain, Javed Masood Khan, Anis Ahmad & Jeyam Muthusamy. (2023) Vaccine candidates for cellulitis from Staphylococcus aureus and Streptococcus pyogenes – In silico approach. Journal of King Saud University - Science 35:9, pages 102917.
Crossref
Crossref
Mohammadhassan Mirali, Abolfazl Jahangiri, Mohammadreza Jalali Nadoushan & Iraj Rasooli. (2023) A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model. Microbial Pathogenesis 182, pages 106262.
Crossref
Crossref
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim & Jae-Hwan Nam. (2023) Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines. Experimental & Molecular Medicine 55:7, pages 1305-1313.
Crossref
Crossref
Simon Collett, Linda Earnest, Julio Carrera Montoya, Melissa A. Edeling, Ashley Yap, Chinn Yi Wong, Dale Christiansen, Jason Roberts, Jamie Mumford, Valerie Lecouturier, Vincent Pavot, Sergio Marco, Joon Keit Loi, Cameron Simmons, Shivali A. Gulab, Jason M. Mackenzie, Aaron Elbourne, Paul A. Ramsland, Garth Cameron, Dhiraj Hans, Dale I. Godfrey & Joseph Torresi. (2023) Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates. Frontiers in Microbiology 14.
Crossref
Crossref
Yongxue Lv, Liangliang Chang, Jihui Yang, Jia Wen, Yinqi Zhao, Mingxing Zhu, Changyou Wu & Wei Zhao. (2023)
Immunogenicity of peptide‐based vaccine composed of epitopes from
Echinococcus granulosus
rEg
.
P29
. The FASEB Journal 37:4.
Crossref
Crossref
Theodora U.J. Bruun, Shaogeng Tang, Graham Erwin, Lindsay Deis, Daniel Fernandez & Peter S. Kim. (2023) Structure-guided stabilization improves the ability of the HIV-1 gp41 hydrophobic pocket to elicit neutralizing antibodies. Journal of Biological Chemistry 299:4, pages 103062.
Crossref
Crossref
Xiuzhen Sheng, Honghua Zhang, Min Liu, Xiaoqian Tang, Jing Xing, Heng Chi & Wenbin Zhan. (2023) Development and Evaluation of Recombinant B-Cell Multi-Epitopes of PDHA1 and GAPDH as Subunit Vaccines against Streptococcus iniae Infection in Flounder (Paralichthys olivaceus). Vaccines 11:3, pages 624.
Crossref
Crossref
Anna M. Hassebroek, Harini Sooryanarain, Connie L. Heffron, Seth A. Hawks, Tanya LeRoith, Thomas E. Cecere, William B. Stone, Debra Walter, Hassan M. Mahsoub, Bo Wang, Debin Tian, Hannah M. Ivester, Irving C. Allen, Albert J. Auguste, Nisha K. Duggal, Chenming Zhang & Xiang‐Jin Meng. (2023) A hepatitis B virus core antigen‐based virus‐like particle vaccine expressing SARS‐CoV‐2 B and T cell epitopes induces epitope‐specific humoral and cell‐mediated immune responses but confers limited protection against SARS‐CoV‐2 infection. Journal of Medical Virology 95:2.
Crossref
Crossref
Georgia F. Papadaki, Omar Ani, Tyler J. Florio, Michael C. Young, Julia N. Danon, Yi Sun, Devin Dersh & Nikolaos G. Sgourakis. (2023) Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules. Frontiers in Immunology 14.
Crossref
Crossref
Aranya Pal, Nibedita Pyne & Santanu Paul. (2023) In-Silico Designing of a Multi-Epitope Vaccine against SARS-CoV2 and
Studying the Interaction of the Vaccine with Alpha, Beta, Delta and Omicron
Variants of Concern. Current Drug Discovery Technologies 20:1.
Crossref
Crossref
Ara Karizza G. Buan, Nico Alexander L. Reyes, Ryan Nikkole B. Pineda & Paul Mark B. Medina. (2022) In silico design and evaluation of a multi-epitope and multi-antigenic African swine fever vaccine. ImmunoInformatics 8, pages 100019.
Crossref
Crossref
Karen Zagorski, Kabita Pandey, Rajesh Rajaiah, Omalla A. Olwenyi, Aditya N. Bade, Arpan Acharya, Morgan Johnston, Shaun Filliaux, Yuri L. Lyubchenko & Siddappa N. Byrareddy. (2022) Modular nanoarray vaccine for SARS-CoV-2. Nanomedicine: Nanotechnology, Biology and Medicine 46, pages 102604.
Crossref
Crossref
Shakilur Rahman & Amit Kumar Das. (2022) A subtractive proteomics and immunoinformatics approach towards designing a potential multi-epitope vaccine against pathogenic Listeria monocytogenes. Microbial Pathogenesis 172, pages 105782.
Crossref
Crossref
Carolina Nunes, Lisa Depestel, Liselot Mus, Kaylee M. KellerLouis Delhaye, Amber Louwagie, Muhammad Rishfi, Alex Whale, Neesha Kara, Simon R. Andrews, Filemon Dela Cruz, Daoqi YouArmaan SiddiqueeCamila Takeno Cologna, Sam De Craemer, Emmy Dolman, Christoph BartenhagenFanny De Vloed, Ellen SandersAline EggermontSarah-Lee BekaertWouter Van Loocke, Jan Willem Bek, Givani DewynSiebe Loontiens, Gert Van Isterdael, Bieke Decaesteker, Laurentijn Tilleman, Filip Van Nieuwerburgh, Vanessa Vermeirssen, Christophe Van Neste, Bart Ghesquiere, Steven GoossensSven Eyckerman, Katleen De Preter, Matthias Fischer, Jon Houseley, Jan Molenaar, Bram De Wilde, Stephen S. Roberts, Kaat Durinck & Frank Speleman. (2022) RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition. Science Advances 8:28.
Crossref
Crossref
Benjamin D. Brooks, Alexander Beland, Gabriel Aguero, Nicholas Taylor & Francina D. Towne. (2022) Moving beyond Titers. Vaccines 10:5, pages 683.
Crossref
Crossref
Yashavantha L. Vishweshwaraiah & Nikolay V. Dokholyan. (2022) Toward rational vaccine engineering. Advanced Drug Delivery Reviews 183, pages 114142.
Crossref
Crossref
Yongxue Lv, Yazhou Zhu, Liangliang Chang, Jihui Yang, Yinqi Zhao, Jiaqing Zhao, Yana Wang, Mingxing Zhu, Changyou Wu & Wei Zhao. (2022) Identification of a dominant murine T-cell epitope in recombinant protein P29 from <italic>Echinococcus granulosus</italic>. Acta Biochimica et Biophysica Sinica 54:4, pages 482-493.
Crossref
Crossref
Abid Ali, Shabir Ahmad, Pedro Machado Medeiros de Albuquerque, Atif Kamil, Fahdah Ayed Alshammari, Abdulaziz Alouffi & Itabajara da Silva VazJr.Jr.. (2021) Prediction of Novel Drug Targets and Vaccine Candidates against Human Lice (Insecta), Acari (Arachnida), and Their Associated Pathogens. Vaccines 10:1, pages 8.
Crossref
Crossref
HuiHui Zhang, Pei Chen, Haojie Ma, Magdalena Woińska, Dejian Liu, David R. Cooper, Guo Peng, Yousong Peng, Lei Deng, Wladek Minor & Heping Zheng. (2021) virusMED: an atlas of hotspots of viral proteins. IUCrJ 8:6, pages 931-942.
Crossref
Crossref
Ester Calvo Fernández & Lucie Y. Zhu. (2021) Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future. British Journal of Clinical Pharmacology 87:9, pages 3408-3424.
Crossref
Crossref
Maryam Bayat, Yahya Asemani & Sajad Najafi. (2021) Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. International Immunopharmacology 97, pages 107679.
Crossref
Crossref
David F. Zeigler, Emily Gage & Christopher H. Clegg. (2021) Epitope-targeting platform for broadly protective influenza vaccines. PLOS ONE 16:5, pages e0252170.
Crossref
Crossref
Jun Ma, Li Wang, Zhaowei Fan, Shuo Liu, Xin Wang, Ran Wang, Jing Chen, Xue Xiao, Siyu Yang, Xuyang Duan, Baifen Song, Jinzhu Ma, Chunyu Tong, Liquan Yu, Yongzhong Yu & Yudong Cui. (2021) Immunogenicity of multi-epitope vaccines composed of epitopes from Streptococcus dysgalactiae GapC. Research in Veterinary Science 136, pages 422-429.
Crossref
Crossref
Christopher D. Thouvenel, Mary F. Fontana, Jason Netland, Akshay T. Krishnamurty, Kennidy K. Takehara, Yu Chen, Suruchi Singh, Kazutoyo Miura, Gladys J. Keitany, Eric M. Lynch, Silvia Portugal, Marcos C. Miranda, Neil P. King, Justin M. Kollman, Peter D. Crompton, Carole A. Long, Marie Pancera, David J. Rawlings & Marion Pepper. (2021)
Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict
Plasmodium
parasites
. Journal of Experimental Medicine 218:4.
Crossref
Crossref
Rula M. Darwish. (2021) COVID-19 immunity and vaccines: what a pharmacist needs to know. Asian Biomedicine 15:2, pages 51-67.
Crossref
Crossref
Shrina P. Patel, Gayatri S. Patel & Jalpa V. Suthar. (2021) Inside the story about the research and development of COVID-19 vaccines. Clinical and Experimental Vaccine Research 10:2, pages 154.
Crossref
Crossref
. (2021) Immunological considerations and vaccines against COVID-19. Biomedical Letters 7:1, pages 54-62.
Crossref
Crossref
Sunil Krishnan G, Amit Joshi, Nahid Akhtar & Vikas Kaushik. (2021) Immunoinformatics designed T cell multi epitope dengue peptide vaccine derived from non structural proteome. Microbial Pathogenesis 150, pages 104728.
Crossref
Crossref
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, Matthew S. Miller, Brian D. Lichty & Zhou Xing. (2020) Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology 20:10, pages 615-632.
Crossref
Crossref
Arwa A. Mohammed, Shaza W. Shantier, Mujahed I. Mustafa, Hind K. Osman, Hashim E. Elmansi, Isam-Aldin A. Osman, Rawan A. Mohammed, Fatima A. Abdelrhman, Mihad E. Elnnewery, Einas M. Yousif, Marwa M. Mustafa, Nafisa M. Elfadol, Alaa I. Abdalla, Eiman Mahmoud, Ahmed A. Yagaub, Yassir A. Ahmed & Mohamed A. Hassan. (2020)
Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah
Henipavirus
Using Immunoinformatics Approaches
. Journal of Immunology Research 2020, pages 1-12.
Crossref
Crossref
Jisang Park, Hyun-Young Lee, Ly Tuan Khai, Nguyen Thi Thu Thuy, Le Quynh Mai & Yong-Suk Jang. (2020) Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity. Vaccines 8:1, pages 88.
Crossref
Crossref
Catherine J. Mitran, Angie Mena, Sedami Gnidehou, Shanna Banman, Eliana Arango, Barbara A. S. Lima, Hazel Lugo, Aravindhan Ganesan, Ali Salanti, Anthony K. Mbonye, Francis Ntumngia, Khaled Barakat, John H. Adams, Flora S. Kano, Luzia H. Carvalho, Amanda E. Maestre, Michael F. Good & Stephanie K. Yanow. (2019)
Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
Plasmodium vivax
PvDBP and
Plasmodium falciparum
VAR2CSA
. mBio 10:5.
Crossref
Crossref
Ynga-Durand, Dekhtiarenko & Cicin-Sain. (2019) Vaccine Vectors Harnessing the Power of Cytomegaloviruses. Vaccines 7:4, pages 152.
Crossref
Crossref
Theresa B. Gallagher, Gabriela Mellado-Sanchez, Ana L. Jorgensen, Stephen Moore, James P. Nataro, Marcela F. Pasetti & Les W. Baillie. (2019) Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis. PLOS Neglected Tropical Diseases 13:8, pages e0007644.
Crossref
Crossref
Daniel Wright, Jeroen Kortekaas, Thomas A. Bowden & George M. Warimwe. (2019) Rift Valley fever: biology and epidemiology. Journal of General Virology 100:8, pages 1187-1199.
Crossref
Crossref
Simon Collett, Joseph Torresi, Linda Earnest-Silveira, Dale Christiansen, Aaron Elbourne & Paul A. Ramsland. (2019) Probing and pressing surfaces of hepatitis C virus-like particles. Journal of Colloid and Interface Science 545, pages 259-268.
Crossref
Crossref
Mokhtar Nosrati, Mandana Behbahani & Hassan Mohabatkar. (2019) Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach. Journal of Biomedical Informatics 93, pages 103160.
Crossref
Crossref
Andrew J. Guy, Vashti Irani, Jack S. Richards & Paul A. Ramsland. (2018) Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1. Malaria Journal 17:1.
Crossref
Crossref